My Quote Request
No products added yet
6505-01-313-4839
20 Products
PODOFIN
PODOPHYLLUM RESIN TOPICAL SOLUTION,USP
NSN, MFG P/N
6505013134839
NSN
6505-01-313-4839
PODOFIN
PODOPHYLLUM RESIN TOPICAL SOLUTION,USP
NSN, MFG P/N
6505013134839
NSN
6505-01-313-4839
MFG
SYOSSET LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 PERCENTAGE, W/V PODOPHYLLUM RESIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SOLUTION IN TINCTURE BENZOIN
Related Searches:
CUD2920
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505013136244
NSN
6505-01-313-6244
CUD2920
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505013136244
NSN
6505-01-313-6244
MFG
ARMCO MEDICAL SUPPLY INC DBA US TRADING
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS PER PACKAGE
Related Searches:
A89I262
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
A89I262
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS FLUPHENAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUPHENAZINE HYDROCHLORIDE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0863-50
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
NDC00003-0863-50
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
MFG
BRISTOL-MYERS SQUIBB COMPANY DBA BRISTOL-MYERS SQUIBB
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS FLUPHENAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUPHENAZINE HYDROCHLORIDE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PROLIXIN
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
PROLIXIN
FLUPHENAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013136246
NSN
6505-01-313-6246
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS FLUPHENAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUPHENAZINE HYDROCHLORIDE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
HYTRIN
TERAZOSIN HYDROCHLO
NSN, MFG P/N
6505013136820
NSN
6505-01-313-6820
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 1 MG; UNIT DOSE; 100'S
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERAZOSIN HYDROCHLORIDE TABLETS 1MG I.S. 100S PG
Related Searches:
NDC00074-3805-11
TERAZOSIN HYDROCHLO
NSN, MFG P/N
6505013136820
NSN
6505-01-313-6820
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 1 MG; UNIT DOSE; 100'S
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERAZOSIN HYDROCHLORIDE TABLETS 1MG I.S. 100S PG
Related Searches:
NDC00019-1323-21
IOVERSOL AND IODINE
NSN, MFG P/N
6505013138361
NSN
6505-01-313-8361
MFG
ENVIROVAC INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH ML. CONTAINS 678 MG. IOVERS0L AND 320 MGL. IODINE,200 ML. BOTTLE
Related Searches:
NDC00019-1323-11
IOVERSOL AND IODINE
NSN, MFG P/N
6505013139548
NSN
6505-01-313-9548
MFG
ENVIROVAC INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH ML. CONTAINS 678 MG. IOVERS0L AND 320 MGL. IODINE,100 ML. BOTTLE
Related Searches:
16300
PERPHENAZINE TABLETS,USP
NSN, MFG P/N
6505013140761
NSN
6505-01-314-0761
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00182-1865-01
PERPHENAZINE TABLETS,USP
NSN, MFG P/N
6505013140761
NSN
6505-01-314-0761
NDC00182-1865-01
PERPHENAZINE TABLETS,USP
NSN, MFG P/N
6505013140761
NSN
6505-01-314-0761
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
TRILAFON
PERPHENAZINE TABLETS,USP
NSN, MFG P/N
6505013140761
NSN
6505-01-314-0761
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00641-0482-25
PHENYLEPHRINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013141155
NSN
6505-01-314-1155
NDC00641-0482-25
PHENYLEPHRINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505013141155
NSN
6505-01-314-1155
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00186-0742-31
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142716
NSN
6505-01-314-2716
NDC00186-0742-31
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142716
NSN
6505-01-314-2716
MFG
VETERANS HEALTH
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.21 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 13.50 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0084 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.0938 POUNDS
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20 ML OMEPRAZOLE ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: W/TAMPER EVIDENT SEAL,EITHER INNER OR OUTER
Related Searches:
NDC00006-0727-28
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC00006-0727-28
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
Related Searches:
NDC00186-0742-28
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC00186-0742-28
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
ASTRA PHARMACEUTICAL PRODUCTS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
Related Searches:
NDC00186-0742-82
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC00186-0742-82
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
ASTRA PHARMACEUTICALS LP
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
Related Searches:
NDC00378-6150-01
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC00378-6150-01
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
MYLAN PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
Related Searches:
NDC51079-0007-20
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC51079-0007-20
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
UDL LABORATORIES INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
Related Searches:
NDC60505-0065-02
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
NDC60505-0065-02
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013142717
NSN
6505-01-314-2717
MFG
FALCON PHARMACEUTICALS LTD
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 2.20 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 40
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.055 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.45 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OMEPRAZOLE EXTENDED-RELEASE CAPSULES 20MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MG OMEPRAZOLE ACTIVE INGREDIENT;PRIMARY CONTAINER CONTENT QTY:A/A;TOTAL PRIMARY CONTAINER QTY:A/A;100 CAPSULES PER PKG;
